However, the DPP-4 inhibitor linagliptin increases the CX3CR1-positive monocytes with enhanced putative vasculoregenerative cells in type 2 diabetes patients with or without DN [19]. The gene discussed is DPP4; the disease is liver dysplastic nodule.